FDA Inspection Shortfall Highlighted By GAO Once Again
This article was originally published in The Gray Sheet
Executive Summary
FDA's "risk-based" inspection policy for device manufacturers is identified by the General Accounting Office in a January report to Congress as one of the "major management challenges and program risks" facing HHS.